← Every applicant
Natco FDA Approvals
8 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATENew drugAug 26, 2026TABLET, ORAL |
| ERIBULIN MESYLATENew drugJun 1, 2026SOLUTION, INTRAVENOUS |
| IDELALISIBNew drugFeb 17, 2026TABLET, ORAL |
| EVEROLIMUSNew drugJan 28, 2025TABLET, FOR SUSPENSION, ORAL |
| TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINENew drugJun 13, 2023TABLET, ORAL |
| GEFITINIBNew drugMay 31, 2023TABLET, ORAL |
| TERIFLUNOMIDENew drugMay 15, 2023TABLET, ORAL |
| THALIDOMIDENew drugApr 27, 2023CAPSULE, ORAL |